Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations
Details
Publication Year 2024-06,Volume 99,Issue #6,Page 1172-1174
Journal Title
American Journal of Hematology
Publication Type
Research article
Abstract
Probability of treatment-free remission (TFR) in CML patients with additional chromosomal abnormalities (ACA) in the Philadelphia-positive clone or variant Philadelphia translocations (ACA/Var-Ph group, blue panel), in those with no cytogenetic abnormality other than the classical Philadelphia translocation (c-Ph group, green panel) and in the subgroups of CML patients with high-risk ACA (HR-ACA, yellow panel) and Var-Ph (red panel).
Publisher
Wiley
Keywords
Humans; *Translocation, Genetic; *Philadelphia Chromosome; *Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/drug therapy; Female; Male; *Remission Induction; Adult; Middle Aged; Chromosome Aberrations; Aged; Adolescent
Department(s)
Clinical Haematology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-07-04 12:38:03
Last Modified: 2024-07-04 12:38:35

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙